Literature DB >> 22749837

High HPV vaccination uptake rates for adolescent girls after regional governmental funding in Shiki City, Japan.

Y Hayashi1, Y Shimizu, S Netsu, S Hanley, R Konno.   

Abstract

BACKGROUND: In Japan, the bivalent HPV vaccine was approved in October, 2009 and became available as a non-routine vaccine from December, 2009. While routine vaccinations are free, the cost and responsibility for non-routine vaccinations are left to the individual. In exceptional circumstances regional governments fund non-routine vaccinations. This was the case in Shiki City, Saitama Prefecture, where a high uptake rate for individual (non-school based) HPV vaccination was obtained. MATERIALS: On January 20, 2010, the mayor of Shiki City announced to the media his decision to vaccinate adolescent girls in Shiki City against HPV. A project team for HPV vaccination was set up in the city's Health Promotion Center. To gain mutual consent for HPV vaccination, senior health professionals, city officials, the head of the board of education, school principals and health-care teachers met several times. The cohort to be vaccinated was 1254 girls aged 12-15 years. Individual notifications were mailed to each girl on April 23, 2010, along with information about the HPV vaccine.
CONCLUSIONS: As of April 10th, 2011, the uptake rate for girls aged 15 years old was 90.7% for the 1st dose. The vaccine registry is managed by the health care system of the city. The success of the HPV vaccination program and high uptake rates in Shiki City is a good model for the nationwide HPV vaccination program that started in February, 2011.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22749837     DOI: 10.1016/j.vaccine.2012.06.038

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Invasive Prenatal Diagnostic Testing Recommendations are Influenced by Maternal Age, Statistical Misconception and Perceived Liability.

Authors:  Talya Miron-Shatz; Sivan R Rapaport; Naama Srebnik; Yaniv Hanoch; Jonina Rabinowitz; Glen M Doniger; Linda Levi; Jonathan J Rolison; Avi Tsafrir
Journal:  J Genet Couns       Date:  2017-06-14       Impact factor: 2.537

Review 2.  Cancer control programs in East Asia: evidence from the international literature.

Authors:  Malcolm A Moore
Journal:  J Prev Med Public Health       Date:  2014-07-31

Review 3.  The Uptake of Human Papillomavirus Vaccination and Its Associated Factors Among Adolescents: A Systematic Review.

Authors:  Alice Yuen Loke; Miu Ling Kwan; Yuen-Ting Wong; Alice Kar Yan Wong
Journal:  J Prim Care Community Health       Date:  2017-11-21

Review 4.  Overcoming Vaccine Hesitancy for Future COVID-19 and HIV Vaccines: Lessons from Measles and HPV Vaccines.

Authors:  Obianuju G Aguolu; Amyn A Malik; Noureen Ahmed; Saad B Omer
Journal:  Curr HIV/AIDS Rep       Date:  2022-09-17       Impact factor: 5.495

5.  Knowledge on HPV Vaccine and Cervical Cancer Facilitates Vaccine Acceptability among School Teachers in Kitui County, Kenya.

Authors:  Moses Muia Masika; Javier Gordon Ogembo; Sophie Vusha Chabeda; Richard G Wamai; Nelly Mugo
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

6.  Web-based recruiting for a survey on knowledge and awareness of cervical cancer prevention among young women living in Kanagawa prefecture, Japan.

Authors:  Etsuko Miyagi; Yoko Motoki; Mikiko Asai-Sato; Masataka Taguri; Satoshi Morita; Fumiki Hirahara; John D Wark; Suzanne M Garland
Journal:  Int J Gynecol Cancer       Date:  2014-09       Impact factor: 3.437

7.  Multimodal Counseling Interventions: Effect on Human Papilloma Virus Vaccination Acceptance.

Authors:  Oroma Nwanodi; Helen Salisbury; Curtis Bay
Journal:  Healthcare (Basel)       Date:  2017-11-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.